BMRN
Biomarin Pharmaceutical Inc
Price:  
63.55 
USD
Volume:  
771,601.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin EV/EBITDA

-34.1%
Upside

As of 2025-02-12, the EV/EBITDA ratio of Biomarin Pharmaceutical Inc (BMRN) is 24.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biomarin's latest enterprise value is 12,412.32 mil USD. Biomarin's TTM EBITDA according to its financial statements is 516.55 mil USD. Dividing these 2 quantities gives us the above Biomarin EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.8x - 17.0x 15.5x
Forward P/E multiples 19.0x - 32.1x 25.9x
Fair Price 31.31 - 54.04 41.86
Upside -50.7% - -15.0% -34.1%
63.55 USD
Stock Price
41.86 USD
Fair Price

Biomarin EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-11 24.03
2025-02-10 24.01
2025-02-07 24.17
2025-02-06 24.32
2025-02-05 24.26
2025-02-04 23.78
2025-02-03 23.62
2025-01-31 23.96
2025-01-30 24.15
2025-01-29 24.00
2025-01-28 23.92
2025-01-27 23.38
2025-01-24 23.36
2025-01-23 23.53
2025-01-22 23.46
2025-01-21 23.65
2025-01-17 23.28
2025-01-16 23.18
2025-01-15 23.30
2025-01-14 24.13
2025-01-13 25.30
2025-01-10 25.44
2025-01-08 25.81
2025-01-07 25.63
2025-01-06 25.33
2025-01-03 25.24
2025-01-02 25.11
2024-12-31 24.83
2024-12-30 24.73
2024-12-27 25.26
2024-12-26 25.31
2024-12-24 25.17
2024-12-23 25.03
2024-12-20 24.81
2024-12-19 24.56
2024-12-18 24.45
2024-12-17 25.37
2024-12-16 24.76
2024-12-13 24.94
2024-12-12 25.03
2024-12-11 24.92
2024-12-10 25.09
2024-12-09 25.23
2024-12-06 25.21
2024-12-05 24.99
2024-12-04 25.12
2024-12-03 23.90
2024-12-02 24.58
2024-11-29 24.94
2024-11-27 24.72